tiprankstipranks
Shield Therapeutics PLC (GB:STX)
LSE:STX

Shield Therapeutics (STX) Technical Analysis

9 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Shield Therapeutics PLC’s (STX) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Shield Therapeutics PLC is a Sell.
Shield Therapeutics PLC’s (STX) 20-Day exponential moving average is 1.68, while Shield Therapeutics PLC’s (STX) share price is 1.85p, making it a Buy.
Shield Therapeutics PLC’s (STX) 50-Day exponential moving average is 2.17, while Shield Therapeutics PLC’s (STX) share price is 1.85p, making it a Sell.

Shield Therapeutics (STX) Pivot Points

May 17, 2024, 07:24 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.51
1.64
1.74
1.87
1.98
2.11
2.21
Fibonacci
1.64
1.73
1.78
1.87
1.96
2.02
2.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (STX) Moving Averages

May 17, 2024, 07:24 AM
Period
Simple
Exponential
MA5
1.82Buy
1.81Buy
MA10
1.69Buy
1.72Buy
MA20
1.55Buy
1.68Buy
MA50
1.82Buy
2.17Sell
MA100
3.81Sell
3.33Sell
MA200
5.98Sell
5.15Sell
Shield Therapeutics PLC’s (STX) 10-Day exponential moving average is 1.72, while Shield Therapeutics PLC’s (STX) share price is 1.85p, making it a Buy.
Shield Therapeutics PLC’s (STX) 100-Day exponential moving average is 3.33, while Shield Therapeutics PLC’s (STX) share price is 1.85p, making it a Sell.
Shield Therapeutics PLC’s (STX) stock price is 1.85p and Shield Therapeutics PLC’s (STX) 50-day simple moving average is 1.82, creating a Buy signal.
Shield Therapeutics PLC’s (STX) stock price is 1.85p and Shield Therapeutics PLC’s (STX) 100-day simple moving average is 3.81, creating a Sell signal.
Shield Therapeutics PLC’s (STX) stock price is 1.85p and Shield Therapeutics PLC’s (STX) 200-day simple moving average is 5.98, creating a Sell signal.

Shield Therapeutics (STX) Technical Indicators

May 17, 2024, 07:24 AM
Name
Value
Implied Action
RSI (14)
55.11
Neutral
STOCH (9,6)
71.75
Neutral
STOCHRSI (14)
79.48
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
40.17
Neutral
Williams %R
-27.84
Buy
CCI (14)
123.08
Sell
ATR (14)
0.19
-
Ultimate Oscillator
58.85
Neutral
ROC
51.64
Buy
Shield Therapeutics PLC’s (STX) Relative Strength Index (RSI) is 55.11, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Trend Strength Indicator (ADX) is 40.17, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Commodity Channel Index (CCI) is 123.08, creating a Sell signal.
Shield Therapeutics PLC’s (STX) Price Rate of Change (ROC) is 51.64, creating a Buy signal.

FAQ

Is STX a Buy, Hold, or Sell?
Based on STX’s technical indicators, STX is a Buy.
    What is STX’s RSI (14)?
    STX’s RSI (14) is 55.11, which suggests STX is a Neutral.
      What is STX’s MACD?
      STX’s MACD is -0.02, which suggests STX is a Sell.
        What is STX’s 5-day moving average?
        STX’s 5-day moving average is 1.82, which suggests STX is a Buy.
          What is STX’s 20-day moving average?
          STX 20-day moving average is 1.55, which suggests STX is a Buy.
            What is STX’s 50-day moving average?
            STX’s 50-day moving average is 1.82, which suggests STX is a Buy.
              What is STX’s 200-day moving average?
              STX’s 200-day moving average is 5.98, which suggests STX is a Sell.
                What is STX’s Williams % R (14)?
                STX’s Williams % R (14) is -27.84, which suggests STX is a Buy.
                  What is STX’s CCI (14)?
                  STX’s CCI (14) is 123.08, which suggests STX is a Sell.
                    What is the share price of Shield Therapeutics PLC?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis